¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Problems related to unspecified psycho- social circumstances"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® social phobia ÇÑ±Û »çȸ°øÆ÷
¼³¸í   
  ´Ù¸¥ »ç¶÷µéÀÌ Àڱ⸦ »ìÇǰí ÃÄ´Ù º¼¼ö Àִ »óȲÀ» µÎ·Á¿öÇÏ°í ±×·± »óȲ¿¡ Ã³Çϸ頼öÄ¡½ÉÀ» ´À³¢´Â °øÆ÷Àå¾Ö(phobic disorder)ÀÇ ÀÏÁ¾. »ç¶÷À» ¸¸³ª±â Àü¿¡ ¹Ì¸® ¿¹»óÇÏ°í ºÒ¾È(anticipatory anxiety: ¿¹»óÀ» Çϴ °Í ÀÚü¸¸À¸·Î ºÒ¾ÈÀ» ´À³¢´Â °Í)À» ½ÉÇϰԠ´À³¢¹Ç·Î »ç¶÷°ú Á¢ÃËÇϴ °ÍÀ» ÇÇÇÑ´Ù. ÈçÇÑ »çȸ °øÆ÷ÁõÀ¸·Î´Â »ç¶÷¾Õ¿¡¼­ ¸»Çϱ⸦ µÎ·Á¿öÇϴ ´ëÈ­°øÆ÷(fear of public speaking), »ç¶÷¾Õ¿¡¼­ ¾ó±¼À» ºÓÈ÷´Â °ÍÀ» µÎ·Á¿öÇϴ Àû¸é°øÆ÷(erythrophobia), »ç¶÷ ¾Õ¿¡¼­ÀÇ ½Ä»ç¸¦ µÎ·Á¿öÇϴ ½Ä»ç°øÆ÷(sitophobia), »ç¶÷ ¾Õ¿¡¼­ÀÇ ±Û ¾²±â¸¦ µÎ·Á¿öÇϴ ¼­ÇʰøÆ÷, °øÁߺ¯¼Ò¸¦ »ç¿ëÇϱ⸦ µÎ·Á¿öÇϴ °øÁߺ¯¼Ò°øÆ÷µîÀÌ ÀÖÀ½. ÀÌ Àå¾Ö´Â ¾Æµ¿±â ÈĹݠȤÀº »çÃá±â Ãʹݿ¡ ½ÃÀ۵Ǹ砰¡Á·ÀûÀ¸·Î ¹ßº´Çϴ °æÇâÀÌ ¸¹´Ù. ÇÕº´ÁõÀ¸·Î´Â °úÀ½, Ç׺ҾȠ¾à¹° ³²¿ë µîÀÌ ÀÖ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • age-related cognitive decline
    ³ªÀ̰ü·ÃÀÎÁöÀúÇÏ
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • breathing related sleep disorder
    È£Èí°ü·Ã¼ö¸éÀå¾Ö
  • calcitonin gene-related peptide
    Ä®½ÃÅä´ÑÀ¯ÀüÀÚ°ü·ÃÆéƼµå
  • diagnosis related group
    Æ÷°ý¼ö°¡Á¦
  • related
    ±ÙÄ£-
  • stress-related disorder
    ½ºÆ®·¹½º°ü·ÃÀå¾Ö
  • sleep-related epilepsy
    ¼ö¸é°ü·Ã°£Áú
  • sleep-related sinus arrest
    ¼ö¸é°ü·Ã±¼¹æ°áÀýÁ¤Áö
  • cognitive social learning
    ÀÎÁö»çȸÇнÀ
  • medical social work
    ÀÇ·á»çȸ»ç¾÷
  • social service model
    »çȸ¼­ºñ½º¸ðµ¨
  • social skills training
    »çȸ±â¼úÈÆ·Ã
  • social withdrawal
    »çȸÀûÀ§Ãà
  • social
    »çȸ-
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diagnosis related group
    Æ÷°ý¼ö°¡Á¦
  • social adjustment
    »çȸÀûÀÀ
  • social class
    »çȸ°èÃþ
  • social medicine
    »çȸÀÇÇÐ
  • skill social
    »çȸ±â¼ú
  • social
    »çȸ-
  • social security
    »çȸº¸ÀåÁ¦µµ, »çȸº¸Àå¹ý
  • medical social worker
    ÀÇ·á»çȸ»ç¾÷°¡
  • social withdrawal
    »çȸÀûÀ§Ãà
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • age-related cognitive decline
    ³ªÀ̰ü·ÃÀÎÁöÀúÇÏ
  • sleep-related sinus arrest
    ¼ö¸é°ü·Ã½ÉÀå¹Úµ¿Á¤Áö
  • breathing related sleep disorder
    È£Èí°ü·Ã¼ö¸éÀå¾Ö
  • diagnosis related group
    À¯»çÁø´Ü±ºÀÇ·áºñÁöºÒ¹ý
  • stress-related disorder
    ½ºÆ®·¹½º°ü·ÃÀå¾Ö
  • tobacco-related disorder
    ´ã¹è°ü·ÃÀå¾Ö
  • sleep-related epilepsy
    ¼ö¸é°ü·Ã°£Áú
  • related
    ±ÙÄ£-
  • social adjustment
    »çȸÀûÀÀ
  • social security act
    »çȸº¸Àå¹ý, »çȸº¸Àå¹ý
  • cognitive social learning
    ÀÎÁö»çȸÇнÀ
  • social class
    »çȸ°èÃþ
  • social clock
    »çȸÀû½Ã°è
  • social hygiene
    »çȸÀ§»ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SOFAS, Social and Occupational Functioning Assessment Scale
    »çȸ-Á÷¾÷±â´ÉÆò°¡Ã´µµ
  • releaser, social
    º»´ÉÀ¯¹ßÀÎÀÚ.
  • ARC => AIDS-related complex
    ÈÄõ¼º¸é¿ª°áÇÌÁõ°ü·ÃÁõÈıº
  • ARMD->age-related macular degeneration
    ¿¬·É°ü·ÃȲ¹Ýº¯¼º,³ë³â±âȲ¹Ýº¯¼º
  • AlDS-related complex
    ÈÄõ¼º¸é¿ª°áÇÌÁõ°ü·ÃÁõÈıº
  • D-related antigen
    D-°ü·ÃÇ׿ø
  • REM-sleep-related sinus arrest
    ·½¼ö¸é °ü·Ã ½ÉÀ嵿°áÀý(Ô×Ì¿ï½) Á¤Áö
  • age-related cognitive decline
    ¿¬·É °ü·Ã ÀÎÁö ÀúÇÏ
  • fructose-related disorder
    ÇÁ¶ôÅ佺°ü·ÃÀå¾Ö<--Áúº´>
  • hallucinogen-related disorder
    ȯ°¢Á¦ °ü·ÃÀå¾Ö(º´)(ü³ÊÆð¥Î¼Ö¤î¡äô)
  • polysubstance-related disorder
    º¹ÇÕ¹°Áú°ü·ÃÀå¾Ö(º´)
  • related
    ±ÙÄ£(ÐÎöÑ)ÀÇ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atmospheric circumstances
    ´ë±âȯ°æ.
  • sibling relational problems
    µ¿±â°£°ü°è¹®Á¦
  • age-related cognitive decline
    ¿¬·É °ü·Ã ÀÎÁö ÀúÇÏ
  • age-related macular degeneration
    ¿¬·É°ü·ÃȲ¹Ýº¯¼º, ³ë³â±âȲ¹Ýº¯¼º
  • antigen, D-related
    D-°ü·ÃÇ׿ø
  • breathing related sleep disorder
    È£Èí°ü·Ã¼ö¸éÀå¾Ö(º´)
  • caffeine - related disorder
    Ä«ÆäÀÎ °ü·ÃÀå¾Ö(º´)
  • calcitonin-gene related peptide
    Ä®½ÃÅä´ÑÀ¯ÀüÀÚ°ü·ÃÆéƼµå
  • cannabis - related disorder
    ´ë¸¶°ü·ÃÀå¾Ö(º´)
  • diagnosis related group(DRG)
    Áø´Ü¸íº° ±º, À¯»çÇÑ Áø´Ü¸íµé³¢¸® ¹­¾î À̸¦ ´ÜÀ§·Î ÀÇ·áºñ¸¦ ÁöºÒÇÏ´Â ¹æ¹ý
  • diagnostic related group
    Áø´Ü°ü·Ã±º
  • epilepsy, sleep-related
    ¼ö¸é¼º °£Áú
  • event-related potential
    »ç°Ç°ü·ÃÀüÀ§(ÞÀËìμ֤ï³êÈ)
  • factor VIII-related antigen
    Á¦ VIII-°ü·ÃÇ׿ø
  • flow related enhancement
    À¯µ¿ °ü·Ã Áõ°­
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • flow related enhancement
    À¯µ¿°ü·ÃÁõ°­
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MSW Master of Social Welfare; Master of Social Work; medical social worker; multiple stab wounds
IPT Interpersonal Psycho-Therapy
ICD I-cell disease; immune complex disease; implantable cardioverter defibrillator; impulse-control diso...
ICD-10 International Statistical Classification of Diseases and Health-related Problems, 10th revision
STANDOUT soft thresholding and depth cueing of unspecified techniques
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
WPSI Washington Psycho-Social Seizure Inventory
DRP Drug Related Problems
ICHPPC International Classification of Health Problems in Primary Care
IIP Inventory of Interpersonal Problems
DHSS Department of Health and Social Security
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Z65.9
    Problems related to unspecified psycho- social circumstances
    »ó¼¼ºÒ¸íÀÇ Á¤½Å»çȸÀû »óȲ¿¡ °ü·ÃµÈ ¹®Á¦
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • unspecified
    ºñƯÀ̼º
    ´Ù¸¥ °ÍÇÏ°í¸¸ Ưº°È÷ °áÇÕÀ» ÇÑ´ÙµçÁö ¹ÝÀÀÇϴ ƯÀ̼ºÀÌ ¾ø´Â.
  • age-related cognitive decline
    ¿¬·É °ü·Ã ÀÎÁö ÀúÇÏ
  • AIDS related complex
    AIDS °ü·Ã º¹ÇÕÁõ, ÈÄõ¼º ¸é¿ª °áÇÌÁõ°ú ¿¬°üµÈ Áúȯ, ÈÄõ¼º ¸é¿ª °áÇÌÁõ-°ü·Ã º¹ÇÕü, ÈÄõ¼º ¸é¿ª °áÇÌÁõ °ü·Ã º¹ÇÕ ¹ÝÀÀ
  • dynorphin-related peptide
    ´ÙÀ̳îÇÉ °ü·Ã ÆéƼµå
  • pain-related disability
    µ¿Åë°ú °ü·ÃµÈ Àå¾Ö
  • parathyroid hormone-related peptide
    ºÎ°©»ó¼± È£¸£¸ó ¿¬°ü ÆéŸÀ̵å
  • polysubstance-related disorder
    º¹ÇÕ ¹°Áú °ü·Ã Àå¾Öº´
  • related
    ±ÙÄ£ÀÇ
  • related heteroantigen
    ÀÌÁ¾ Ç׿ø
  • related sulfonamide diuretics

    relation (À§Ä¡, °ü°è

    ¾î´À ¹°Ã¼ ¶Ç´Â ½Çü°¡ µý °Í°ú °ü·ÃÀ» °¡Áö°í ÀÖ´Ù°í »ý°¢µÇ´Â »óÅÂ.
  • systemic related problem
    Àü½ÅÀû ¹®Á¦
  • impaired social activity
    »çȸÀû Ȱµ¿ Àå¾Ö
  • medical social service department
    ÀÇ·á»çȸ»ç¾÷ºÎ
  • social
    »çȸ
    ¼­·Î Çù·ÂÇÏ¿© °øµ¿ »ýȰÀ» ÇÏ´Â ÀηùÀÇ Áý´Ü ¶Ç´Â ¿Â°® ÇüÅÂÀÇ Àΰ£ÀÇ Áý´ÜÀû »ýȰ. ÀÚ¿¬ÀûÀ¸·Î ¹ß»ýµÈ Áý´Ü°ú ÀÎÀ§ÀûÀ¸·Î ƯÁ¤ÇÑ ÀÌÇØ ¹× ¸ñÀûÀ» °¡Áö°í Çü¼ºÇÑ Áý´ÜÀÇ µÑ·Î ³ª´­ ¼ö ÀÖ´Ù.
  • social behavior
    »çȸÀû Çൿ, »çȸ Çൿ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
social problems Situations affecting a significant number of people, that are believed to be sources of difficulty or threaten the stability of the community, and that require programs of amelioration.
(12 Dec 1998)
psycho- <prefix> A combining form from Gr. The soul, the mind, the understanding; as, psychology.
(29 Oct 1998)
psycho-oncology The psychological aspects of the treatment and management of the patient with cancer; it combines elements of psychiatry, psychology, and medicine with special concern for the psychosocial needs of the patient and his/her family.
(05 Mar 2000)
International Classification of Health Problems in Primary Care A classification of diseases, conditions and problems arranged for use in primary care where diagnostic precision is seldom possible.
(05 Mar 2000)
adhesion-related kinase <chemical> New member of the immunoglobulin superfamily with 2 immunoglobulin-like domains
Synonym: ark protein, ark receptor tyrosine kinase
(26 Jun 1999)
age-related macular degeneration A common macular degeneration beginning with drusen of the macula and pigment disruption and sometimes leading to severe loss of central vision.
(05 Mar 2000)
aids-related complex A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating aids-related complex (arc) from aids include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in aids; follicular or mixed hyperplasia in arc lymph nodes, leading to lymphocyte degeneration and depletion more typical of aids; evolving succession of histopathological lesions such as localization of kaposi's sarcoma, signaling the transition to the full-blown aids.
(12 Dec 1998)
aids-related opportunistic infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include pneumocystis carinii pneumonia, kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with mycobacterium avium complex, microsporidium, and cytomegalovirus.
(12 Dec 1998)
AIDS-related virus An obsolete term for human immunodeficiency virus.
(05 Mar 2000)
alcohol-related disorders Mental disorders related or resulting from abuse or mis-use of alcohol.
(12 Dec 1998)
amphetamine-related disorders Disorders related or resulting from use of amphetamines.
(12 Dec 1998)
angiotensin-related carboxypeptidase <enzyme> Rat and bovine brain synaptosomal enzyme can hydrolyze angiotensin I to des-leu angiotensin I, but no further
Registry number: EC 3.4.-
Synonym: angiotensin-specific carboxypeptidase
(26 Jun 1999)
calcitonin gene-related peptide <protein> A second product transcribed from the calcitonin gene. Calcitonin gene related peptide is found in a number of tissues including nervous tissue. It is a vasodilator that may participate in the cutaneous triple response.
It is a neuropeptide of 37 amino acids with structural homology to salmon calcitonin. Co-localises with substance P in neurons. It occurs as a result of alternative processing of mRNA from the calcitonin gene.
The neuropeptide is widely distributed in neural tissue of the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.
Intracerebral administration leads to a rise in noradrenergic sympathetic outflow, a rise in blood pressure and a fall in gastric secretion.
Acronym: CGRP
(05 May 2002)
MAK-related kinase <enzyme> A cdc2-related serine/threonine kinase; shows 87% idnetity to the male-germ cell associated kinase (mak); mw 66 kD; genbank d26178
Registry number: EC 2.7.10.-
Synonym: mrk kinase
(26 Jun 1999)
receptors, calcitonin gene-related peptide Cell surface proteins that bind calcitonin gene-related peptide (cgrp) with high affinity and trigger intracellular changes which influence the behaviour of cells. Cgrp receptors are present in both the central nervous system and the periphery and are not the same as calcitonin receptors.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • unspecified
    Ư±â
  • circumstances
    ȯ°æ
  • psycho
    ½É¸®ÇÐÀÇ ¶æ
  • mitigating circumstances
    (Çü±â µîÀÇ) °æ°¨ »çÀ¯;ÂüÀÛÇÒ Á¤»ó
  • psycho
    Á¤½Åº´ÀÚ;Á¤½ÅºÐ¼®;Á¤½Åº´ÇÐÀÇ;½Å°æÁõÀÇ;Á¤½Å ÀÇÇÐÀÇ;Á¤½Å ºÐ¼®ÇÏ´Ù
  • related
    °ü°è°¡ ÀÖ´Â
  • Earnings Related Supplement
    (¿µ)º¸Çè ±ÞºÎ±Ý(¿µ±¹ÀÇ »çȸº¸ÀåÁ¦µµ¿¡¼­ 6°³¿ù°£ ½Ç¾÷ÀÚ(ȯÀÚ)¿¡°Ô Àü³âµµ ¼Òµæ¿¡ µû¶ó Áö±ÞµÊ)
  • related
    °ü°è°¡ ÀÖ´Â;°ü·ÃµÈ;Ä£Á·ÀÇ;µ¿Á·ÀÇ
  • related key
    (ÁÖÀ½ µî°ú °¡±î¿î °ü°è°¡ ÀÖ´Â)±ÙÄ£(°ü°è)Á¶
  • social
    »çȸÀÇ,»ç±³ÀûÀÎ
  • Economic and Social Council
    =ECOSOC
  • Social Credit
    »çȸ ä±Ç¼³
  • Social Democracy
    »çȸ ¹ÎÁÖÁÖÀÇ
  • Social Register
    ¸í»ç·Ï
  • social
    »çȸÀÇ(¿¡ °üÇÑ);»çȸ(»ç±³)ÀûÀÎ;ºÙÀÓ¼º ÀÖ´Â;»çȸÁÖÀÇÀÇ;»çȸ»ýȰÀ» ¿µÀ§ÇÏ´Â;Ä£¸ñȸ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á